Haihe Biopharma Grants Taiho Pharmaceutical Exclusive License for Risovalisib in Japan
China‑based Haihe Biopharma Co., Ltd. (the “Licensor”) announced today that it has entered into an...
Taiho Pharmaceutical
Taiho Pharmaceutical to Acquire Araris Biotech for USD 400 Million, Expanding ADC Portfolio
Japan-based Taiho Pharmaceutical Co., Ltd. announced plans to fully acquire Araris Biotech AG, a Swiss...
Haihe Pharmaceuticals Licenses Glumetinib to Taiho for Exclusive Development in Japan and Asia
Shanghai Haihe Pharmaceutical Co., Ltd has entered into a licensing agreement with Taiho Pharmaceutical Co.,...